Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury-Reference-Cited by-同舟云学术

Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury

Published:2010-11 Issue:11 Volume:30 Page:2136-2142
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Antoniak Silvio¹,Rojas Mauricio¹,Spring Denise¹,Bullard Tara A.¹,Verrier Edward D.¹,Blaxall Burns C.¹,Mackman Nigel¹,Pawlinski Rafal¹

Affiliation:

1. From the Division of Hematology/Oncology (S.A., M.R., N.M., and R.P.), Department of Medicine, UNC McAllister Heart Institute, University of North Carolina at Chapel Hill; the Division of Cardiothoracic Surgery (D.S. and E.D.V.), University of Washington, Seattle; and the Aab Cardiovascular Research Institute (T.A.B. and B.C.B.), University of Rochester Medical Center, Rochester, NY.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference59 articles.

1. Thrombin signalling and protease-activated receptors

2. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

3. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

4. Local Protease Signaling Contributes to Neural Tube Closure in the Mouse Embryo

5. The Cardiovascular Actions of Protease-Activated Receptors

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase—Bridging Basic Research to Clinical Findings;Biomolecules;2024-08-07

2. Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2–ERK 1/2 pathway;PLOS ONE;2024-05-15

3. Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways;PeerJ;2023-09-27

4. Emerging roles of protease-activated receptors in cardiometabolic disorders;Journal of Cardiology;2023-04

5. Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging;European Journal of Medicinal Chemistry;2023-01